share_log

CNS Pharmaceuticals | 10-K: FY2023 Annual Report

SEC ·  Apr 1 17:04
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more